Bloodstream infections among solid organ transplant recipients: Epidemiology, microbiology, associated risk factors for morbility and mortality

Transplantation Reviews

Volumn 28, Issue 4, 2014, Pages 176-181

  Shao, Mingjie ^a   Wan, Qiquan ^a   Xie, Wenzhao ^a   Ye, Qifa ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTEREMIA; BLOODSTREAM INFECTION; GRAFT RECIPIENT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFECTION RISK; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MENTAL HEALTH; MORBIDITY; MORTALITY; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; REVIEW; SEPTICEMIA; ADVERSE EFFECTS; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; INCIDENCE; MICROBIOLOGY; RISK FACTOR;

BACTEREMIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; ORGAN TRANSPLANTATION; RISK FACTORS;

EID: 84908085323     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2014.02.001     Document Type: Review

References (83)

1. Fishman J.A. Infection in solid-organ transplant recipients. N Engl J Med 2007, 357:2601-2614.
2. Moreno A., Cervera C., Gavalda J., et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant 2007, 7:2579-2586.
3. Kusne S., Dummer J.S., Singh N., et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine 1988, 67:132-143.
4. George D.L., Arnow P.M., Fox A.S., et al. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 1991, 13:387-396.
5. Wagener M.M., Yu V.L. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents; risk factors, and outcomes. Am J Infect Control 1992, 20:239-247.
6. Singh N., Gayowski T., Wagener M.M., et al. Bloodstream infections in liver transplant recipients receiving tacrolimus. Clin Transplant 1997, 11:275-281.
7. Candel F.J., Grima E., Matesanz M., et al. Bacteremia and septic shock after solid-organ transplantation. Transplant Proc 2005, 37:4097-4099.
8. Singh N., Wagener M.M., Obman A., et al. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004, 10:844-849.
9. Singh N., Gayowski T., Rihs J.D., et al. Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl 2001, 7:22-26.
10. Sigurdsson L., Reyes J., Kocoshis S.A., et al. Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. Transplantation 2000, 70:302-305.
11. Shields R.K., Minces L., Kwak E.J., et al. Bloodstream infections in intestinal transplant recipients are associated with low mortality rates despite the predominance of late-onset infections and the emergence of serratia and other gram-negative bacteria. 48th Annual Meeting of the Infectious Diseases Society of America, Vancouver, BC, October 21-24, 2010 2010, [Abstract 1255], Infectious Diseases Society of America.
12. McClean K., Kneteman N., Taylor G. Comparative risk of bloodstream infection in organ transplant recipients. Infect Control Hosp Epidemiol 1994, 15:582-584.
13. Moreno A., Mensa J., Almela M., et al. 138 Episodes of bacteremia or fungemia in patients with solid organ (renal or hepatic) transplantation. Med Clin (Barc) 1994, 103:161-164.
14. Lee S.O., Kang S.H., Abdel-Massih R.C., et al. Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management. Liver Transpl 2011, 17:733-741.
15. Linares L., García-Goez J.F., Cervera C., et al. Early bacteremia after solid organ transplantation. Transplant Proc 2009, 41:2262-2264.
16. Palmer S.M., Alexander B.D., Sanders L.L., et al. Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. Transplantation 2000, 69:2360-2366.
17. Kim S., Kim Y., Jun Y., et al. Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients. Yonsei Med J 2009, 50:112-121.
18. Iida T., Kaido T., Yagi S., et al. Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl 2010, 16:1379-1385.
19. Hashimoto M., Sugawara Y., Tamura S., et al. Bloodstream infection after living donor liver transplantation. Scand J Infect Dis 2008, 40:509-516.
20. Hsu R.B., Chang C.I., Fang C.T., et al. Bloodstream infection in heart transplant recipients: 12-year experience at a university hospital in Taiwan. Eur J Cardiothorac Surg 2011, 40:1362-1367.
21. Florescu D.F., Qiu F., Langnas A.N., et al. Bloodstream infections during the first year after pediatric intestinal transplantation. Pediatr Infect Dis J 2012, 31:700-704.
22. Akhter K., Timpone J., Matsumoto C., et al. Six-month incidence of bloodstream infections in intestinal transplant patients. Transpl Infect Dis 2012, 14:242-247.
23. Al-Hasan M.N., Razonable R.R., Eckel-Passow J.E., et al. Incidence rate and outcome of gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant 2009, 9:835-843.
24. Hsu J., Andes D.R., Knasinski V., et al. Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients. Eur J Clin Microbiol Infect Dis 2009, 28:1343-1351.
25. Danziger-Isakov L.A., Sweet S., Delamorena M., et al. Epidemiology of bloodstream infections in the first year after pediatric lung transplantation. Pediatr Infect Dis J 2005, 24:324-330.
26. Kawecki D., Kwiatkowski A., Michalak G., et al. Etiologic agents of bacteremia in the early period after simultaneous pancreas-kidney transplantation. Transplant Proc 2009, 41:3151-3153.
27. Singh R.P., Farney A.C., Rogers J. Analysis of bacteremia after pancreatic transplantation with enteric drainage. Transplant Proc 2008, 40:506-509.
28. Rabkin D.G., Stifelman M.D., Birkhoff J., et al. Early catheter removal decreases incidence of urinary tract infections in renal transplant recipients. Transplant Proc 1998, 30:4314-4316.
29. Osman Y., Ali-El-Dein B., Shokeir A.A., et al. Routine insertion of ureteral stent in live-donor renal transplantation: is it worthwhile. Urology 2005, 65:867-871.
30. Wade J.J., Rolando N., Hallar K., et al. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995, 21:1328-1366.
31. Bodro M., Sabé N., Tubau F., et al. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation 2013, 96(9):843-849.
32. Johnson L.E., D'Agata E.M., Paterson D.L., et al. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients. Transpl Infect Dis 2009, 11:227-234.
33. Kaido Toshimi, Mori Akira, Ogura Yasuhiro, et al. Pre- and perioperative factors affecting infection after living donor liver transplantation. Nutrition 2012, 28:1104-1108.
34. Rhee K.W., Oh S.H., Kim K.M., et al. Early bloodstream infection after pediatric living donor liver transplantation. Transplant Proc 2012, 44:794-796.
35. Saner F.H., Olde Damink S.W.M., Pavlakovic G., et al. Pulmonary and bloodstream infections in adult living donor and cadaveric liver transplant patients. Transplantation 2008, 85:1564-1568.
36. Singh N., Paterson D.L., Gayowski T., et al. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000, 6:54-61.
37. Bert F., Larroque B., Paugam-Burtz C., et al. Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transpl 2010, 16:393-401.
38. Bedini A., Codeluppi M., Cocchi S., et al. Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. Transplant Proc 2007, 39:1947-1949.
39. Bellier C., Bert F., Durand F., et al. Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int 2008, 21:755-763.
40. Shi S.H., Kong H.S., Xu J., et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis 2009, 11:405-412.
41. Shi S.H., Kong H.S., Jia C.K., et al. Coagulase-negative Staphylococcus and Enterococcus as predominant pathogens in liver transplant recipients with gram-positive coccal bacteremia. Chin Med J 2010, 123:1983-1988.
42. Falagas M.E., Snydman D.R., Griffith J., Werner B.G. Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Clin Infect Dis 1996, 23:468-474. The Boston Center for Liver Transplantation CMVIG Study Group.
43. Abbott K.C., Oliver J.D., Hypolite I., et al. Hospitalizations for bacterial septicemia after renal transplantation in the United States. Am J Nephrol 2001, 21:120-127.
44. Silva M., Marra A.R., Pereira C.A., et al. Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome. Transplantation 2010, 90:581-587.
45. Foley J.M., Paunio M., Lyytikainen O., et al. Bacteremia among kidney transplant recipients: a case-control study of risk factors and shortterm outcomes. Scand J Infect Dis 2000, 32:69-73.
46. Wu S.W., Liu K.S., Lin C.K., et al. Community-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection. J Formos Med Assoc 2013, 112:138-143.
47. Nieto-Rodriguez J.A., Kusne S., Mañez R., et al. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg 1996, 223:70-76.
48. Rodriguez C., Munoz P., Rodriguez-Creixems M., et al. Bloodstream infections among heart transplant recipients. Transplantation 2006, 81:384-391.
49. Panjwani D.D., Kalawi M., Kumar M.S.A., et al. Septicemia in renal transplant recipients: epidemiology and prognosis. Transplant Proc 1989, 21:2112-2113.
50. Korvick J.A., Marsh J.W., Starzl T.E., et al. Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem. Surgery 1991, 109:62-68.
51. Malinis M.F., Mawhorter S.D., Jain A., et al. Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients. Transplantation 2012, 93:1045-1050.
52. Wan Q., Xiao X., Ye Q., et al. Risk factors for bloodstream infections in liver or kidney transplantation recipients. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2012, 37:924-927.
53. Wan Q., Ye Q., Zhou J. Mortality predictors of bloodstream infections in solid-organ transplant recipients. Exp Clin Transplant 2013, 11:211-214.
54. Wan Q.Q., Ye Q.F., Ming Y.Z., et al. The risk factors for mortality in deceased donor liver transplant recipients with bloodstream infections. Transplant Proc 2013, 45:305-307.
55. Torre-Cisneros J., Herrero C., Canas E., et al. High mortality related with Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2002, 21:385-388.
56. Plevak D.J., Southorn P.A., Narr B.J. Intensive care unit experience in the Mayo liver transplant program: the first 100 cases. Mayo Clin Proc 1989, 64:433-445.
57. Shieh R.M., Chen C.L., Wang K.L. Respiratory changes and pulmonary complications following orthotopic liver transplantation. Transplant Proc 1992, 24:1486-1488.
58. Husain S., Chan K.M., Palmer S.M., et al. Bacteremia in lung transplant recipients in the current era. Am J Transplant 2006, 6:3000-3007.
59. Lin M.F., Lau Y.J., Hu B.S., et al. Bacteremia in renal transplant recipients: retrospective analysis of 60 episodes in a teaching hospital. Zhonghua Yi Xue Za Zhi (Taipei) 2001, 64:108-114.
60. Leigh D.A. Bacteraemia in patients receiving human cadaveric renal transplants. J Clin Pathol 1971, 24:295-299.
61. Nielsen H.E., Korsager B. Bacteremia after renal transplantation. Scand J Infect Dis 1977, 9:111-117.
62. Morduchowicz G., Pitlik S.D., Shapira Z., et al. Infections in renal transplant recipients in Israel. Isr J Med Sci 1985, 21:791-797.
63. Fernández-Ruiz M., López-Medrano F., Varela-Peña P., et al. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection. Am J Transplant 2012, 12:2763-2773.
64. Kawecki D., Chmura A., Pacholczyk M., et al. Etiological agents of bacteremia in the early period after liver transplantation. Transplant Proc 2007, 39:2816-2821.
65. Sganga G., Spanu T., Bianco G., et al. Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles. Transplant Proc 2012, 44:1973-1976.
66. Perić Z., Tambić-Andrasević A., Mrzljak A., et al. Bloodstream infections after liver and hematopoietic stem cell transplantation. Acta Med Croatica 2012, 66:365-373.
67. Serefhanoglu K., Timurkaynak F., Arslan H., et al. Bacteremia among liver and kidney transplant recipients: etiologic agents and antimicrobial susceptibilities. Braz J Infect Dis 2011, 15:408-409.
68. Loinaz C., Kato T., Nishida S., et al. Bacterial infections after intestine and multivisceral transplantation. Transplant Proc 2003, 35:1929-1930.
69. Al-Hasan M.N., Razonable R.R., Kremers W.K., et al. Impact of Gram-negative bloodstream infection on long-term allograft survival after kidney transplantation. Transplantation 2011, 91:1206-1210.
70. Silveira F.P., Marcos A., Kwak E.J., et al. Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion. J Infect 2006, 53:241-247.
71. Bert F., Galdbart J.-O., Zarrouk V., et al. Association between Staphylococcus aureus nasal carriage and infection in liver transplant recipients. Clin Infect Dis 2000, 31:1295-1299.
72. Levin A.S., Barone A.A., Penco J., et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant P. aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999, 28:1008-1011.
73. Montoya J.G., Giraldo L.F., Efron B., et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis 2001, 33:629-640.
74. Smart F.W., Naftel D.C., Costanzo M.R., et al. Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1996, 15:329-341.
75. Garner J.S., Jarvis W.R., Emori T.G., et al. CDC definitions of nosocomial infections. Am J Infect Control 1988, 16:128-140.
76. Bert F., Bellier C., Lassel L., et al. Risk factors for Staphylococcus aureus infection in liver transplant recipients. Liver Transpl 2005, 11:1093-1099.
77. Ballout A., Goffin E., Yombi J.C., et al. Vaccinations for adult solid organ transplant recipient: current recommendations. Transplant Proc 2005, 37:2826-2827.
78. Duchini A., Goss J.A., Karpen S., et al. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003, 16:357-364.
79. Kumar D., Chen M.H., Wong G., et al. A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients. Clin Infect Dis 2008, 47:885-892.
80. Barton M., Wasfy S., Dipchand A.I., et al. Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: a prospective study of safety and immunogenicity. Pediatr Infect Dis J 2009, 28:688-692.
81. Chesi C., Günther M., Huzly D., et al. Immunization of liver and renal transplant recipients: a seroepidemiological and sociodemographic survey. Transpl Infect Dis 2009, 11:507-512.
82. Dengler T.J., Strnad N., Bühring I., et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 1998, 66:1340-1347.
83. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006, 355:2725-2732.